THE CRITICAL ANALYSIS ON DIAGNOSIS OF DISSEMINATED INTRAVASCULAR COAGULATION WITH SCREENING TESTS–A SCORING SYSTEM AND RELATED LITERATURE REVIEW

Authors

  • Bing H. Tang

Abstract

Background: The aim of this study is to assess confidence in the diagnosis of DisseminatedIntravascular Coagulation (DIC); to evaluate the clinical significance of the haemostatic tests; todisclose any respective associations of such tests with patients’ prognosis; and to review therelated literature. It is a retrospective case series study in Changhua Christian Hospital, Taiwan.Methods: Ninety-four patients’ data were analyzed. A scoring system was constructedretrospectively. Results: Hypotheses were postulated and proved. Each patient had a minimalscore of 5, whereas those patients who had reached (increased) their scores were to the full or evenover the maximal level (6 or 9) respectively. There was almost no correlation between age andProthrombin Time (PT). The correlation between age and platelet count, and that between age andfibrinogen were positively minor respectively, whereas that of Activated Partial ThromboplastinTime (APTT) was +0.208. The correlations between APTT and PT, platelet count, fibrinogenrespectively were significant. About 45.67% of patients had plasma fibrinogen >200 mg/dL, while22.23% had <100 mg/dL. A paradox was observed. The finding of such a limited package of thescreening tests was discussed. Related literature with regard to the clinical significance andpitfalls, as well as limitations and strengths of these haemostatic tests were reviewed andevaluated. Conclusion: There are 14 points of impression with clinical significance outlined.Keywords: DIC, Surgical Intensive Care Unit, Laboratory diagnosis, Haemostatic test, Screening test.

References

Sherry, S.: Fibrionlysis, Annu al Review of Medicine, Vol.

:247, Edited by Graff, AC an d Crier, WP, Palo Alto,

Annual Reviews Inc., 1968.

Back, N. and Ambrose, JL. Fibrinolysis, Surgical Bleeding,

A Handbook for Medicine, Surge ry and Specialties, p 390,

edited by Ulin, AW and Golub, S, 1966.

Moltke, P. Plasminogen Activator in Lepto meninges, Proc.

Soc. Exp. Biol. Med. 1958;98:377.

Ratnoff, DD. Some relationships among hemos tasis,

fibrinolytic phenomence, immun ity and the inflammatory

process. Advances Immun. 1969;10:145.

Colman, RW, Girey, GJD, Zacest, R, and Talamo, RC. The

human plasmin kallikrein -kinin system, Progress in

hematology, Vol. 7, edited by Brown, EB and Moore.

Colman, RW. Activation of plas minogen by human plasma

kallikrein. Biochem. Biophys. Res. Commun., 1969;35:273.

Abildgaard, CF. Recognition an d treatment of intravascular

coagulation, J. Pediat., 1969;74:163.

Harsaway, RM. Syndromes of Disseminated Intr avascular

Coagulation, Springfield, III, Charles C Thomas, 1966.

Ingram, GIC . The defibrination syndrome, in Rec ent

Advances in Blood Coagulation, edited by Poller, L. London,

Churchill, p 263, 1969.

McGehie, WG, Rapaport, SD , and Hjort, P. Intravascular

coagulation in fulminant menin gocoiemia, Ann. Int. Med.,

;67:250

McKay, DG. D isseminated Intravascular Coagulation. An

Intermediary Mechanism of Disease. New York, Hoeber, 1965.

Merskey, G, Johnson, AJ, Klein er, GJ, and Wohl, H. The

defibrination syndrome: clinic al features and laboratory

diagnosis. Brit. J. Haemat. 1967;13:528-49.

Rodriquez-Erdmann, F. Bleeding due to increased intravascular

blood coagulation: hemorrhagic syndromes caused by

consumption of blood clotting factors (consumption

coagulopathies). New Eng. J. of Med. 1965;273:1370-8.

Rosner, F, and Ritz, ND. The defrination syndrome. Archives

of Internal Medicine, 1966;117:17-24.

Verstraete, M, Vermylen, C, Ve rmylen, J , and

Vandenbroucke, J. Excessive co nsumption of blood

coagulation components as cause of hemorrhagi c diathesis,

Amer. J. Med., 1965;38:899-908.

Sicuteri, F, Fancuillacri, M, Bavazzaro, A, Franchi, G, and

Del Branco, PL. Kinins and intracranial hemorr hage,

Angiology 1970;21:193-210.

Dalainas A. Pathogenesis, diagnosis, and m anagement of

disseminated intravascular coa gulation. Eur Rev Med

Pharmacol Sci 2008;12(1):19-31.

Kivan, HC, and McFadzcan, AJS. Plasma fibrinolytic activity

induced by ischaemia, Clin. Sci., 1956;15:245.

Taylor Jr FB, Toh C, Hoots WK, Levi M. The 21th Scientific

and standardization committee communications Towards

definition, clinical and laboratory criteria, and a scoring system

for disseminated intravascular coagulation On behalf of the

scientific subcommittee on dis seminated intravasccular

coagulation (DIC) of the international society on thrombosis

and haemostasis (ISTH), Thromb. Haemost 2001;86:1327-30.

Cate H, Bauer KA, Levi M, Edgi ngton TS, Sublett RD,

Barzegar S, Kass BL, Rosenberg RD. The activation of factor

X and prothrombin by recombina nt factor VIIa in vivo is

mediated by tissue factor. J Clin Invest. 1993;92:1207-12.

Oeth P, Parry GCN, Mackman N. Regulatio n of the tissue

factor gene in human monocytic cells. Arterloscler Thromb

Vasc Biol. 1997;17:365-74.

Muller-Berghaus G, ten Cate H, Levi M. Disseminate d

intravascular coagulation: clinical spectrum and established

as well as n ew diagnostic approaches. Thro mbosis and

Haemostasis 1999;82(2):706-12.

J Ayub Med Coll Abbottabad 2007;19(4)

Tang, B. Disseminated Intravas cular Coagulation.

Neurotraumatology. Nov. 20, 1999, Monduzzi Editore, Italy, pp

-41.

Bone RC, Gram-positive organisms and sepsis. Arch Intern

Med. 1994;154:26-4.

Levi M, van der Poll T, ten Ca te H, van Deventer SJH. The

cytokine-mediated imbalance between coa gulant and

anticoagulant mechanisms in sepsis and endotoxemis, Eur J

Clin Invest. 1997;27:3-9.

Dean RT, Prydz H. Inflammatory particles stimulate

thromboplastin production by h uman monocytes. Thromb

Res. 1983;30:357-67.

Thap LC, Supanaranond W, Treeprasertsuk S, Kitvatanachai

S, Chinprasatsak S, Phonrat B. Septic shock second ary to

scrub typhus: characteristics and complications. Southeast

Asian J Trop Med Public Health. 2002 Dec;33(4):780-6.

Gando S, Kameue T, Nanzaki S, Nakanishi Y. Disseminated

intravascular coagulation is a frequent complication of

systemic inflammatory respons e syndrome. Thromb

Haemost1996;75:224-8.

Muller-Berghaus G, Madlener K, Blomback M, ten Cate JW,

eds. DIC. Pathogenesis, Diagno sis and Therapy of

Disseminated Intravascular Fib rin Formation. New York:

Elsevier Science Publishers; 1993.

Bick RL. Disseminated intravascular coagulation: a common

complication of trauma and shock. In: Borris Lc, Lassen MR,

Bergqvist D, eds. The Traumati zed Patient City: Romer

Grafik; 1992:33-53.

Rouman JMH, Hendriks T, van de r Ven J, Nieuwenhuijzen

GAP, Sauerwein RW, van der Mee r JWWM, Goris RJA.

Cytokine patterns in patients after major vascular surgery,

hemorrhagic shock, and severe blunt trauma. Ann Surg.

;6:769-76.

Scherer RU, Spangenberg P, Procoagulant activity in patients

with isolated head trauma. Crit Care Med. 1998;26:149-56.

Wada H, Mori Y, Okabayashi K, Gabazza EC, Kushiya F,

Watanabe M, et al. High Plasma Fibrinogen level is

associated with poor clinical outcome in DIC patients. Am J

Hematol. 2003 Jan;72(1):1-7.

Moscarella S. Ventimiglia V. T hrombotest (TT) and

Normotest (NT). Moscarella S. Ventimiglia V. Quaderni

Sclavo di Diagnost ica Clinica e di Laboratorio.

;10(4):463-73.

Moster ML Coagulopathies and a rterial stroke. J of Neuro -

Ophthalmology. 2003;23(1):63-71.

Arocha-Pinango CL, Guerrero B. Hemorr hagic syndrome

induced by caterpillars. Clini cal and experimental studies.

Invest Clin. 2003 June;44(2):155-63.

Hirshberg A. Dugas M. Banez EI . et al. Minimizing

dilutional coagulopathy in exs anguinating hemorrhage: a

computer stimulation. Journal of Trauma-Injury Infection &

Critical Care. 2003;54(3):454-63.

Rogalski C. Paasch U. Gla nder HJ. Haustein UF. Bullous

pyoderma gangrenosum complicat ed by disseminated

intravascular coagulation with subsequent myelodysplastic

syndrome (chronic myelomonocyt ic leukemia). Journal of

Dermatology. 2005;30(1):59-63.

Smith EY, Charles LA., Van Cot t EM. Biphasic activated

partial thromboplastin time waveform and adverse events in

non-intensive care unit patients. American Journal of Clinical

Pathology. 2004;121(1):138-41.

Toh CH., Giles AR et al. Waveform analysis of clotting test

optical profiles in t he diagnosis and management of

disseminated intravascular coa gulation (DIC). Clinical &

Laboratory Haematology. 2002;24(6):321-7.

Toh CH. Samis J. Downey C. et a l. Biphasic transmittance

waveform in the APTT coagulati on assay is due to the

formation of a Ca++-dependent complex of C-reactive protein

with very-low-density lipoprotein and is a n ovel marker of

impending disseminated intrava scular coagulation. Blood.

;100(7):2522-9.

Mant MJ. Hirsh J. Pineo GF. Lu ke KH. Prolonged

prothrombin time and partial thromboplastin time in

disseminated intravascular coagulation not due to deficiency

of factors V and VIII.British Journal of Haematolog y.

;24(6):725-734.

Kagawa K. Fukutake K. Prothrom bin Time and its

standardization: a potentialit y to introduce INR me thod in

criteria for disseminated intr avascular coagulation].

[Japanese] Rinsho Byori Japanese Journal of Clinical

Pathology. 2002;50(3):277-282.

Muller-Berghaus G, ten Cate H, Levi M , Disseminated

intravascular coagulation. In: Verstraete M, Fuster V, Topol

EJ, eds. Cardlovascular Thrombosis: Thrombocardiology and

Thromboneurology, 2nd E dition. Lippincott -Raven

Publishers, New York; 1998; 781-99.

Gibney EJ, Bouchier-Hayes D. Coagulopathy and abdominal

aortic aneurysm. Eur J Vasc Surg. 1990;4:557-62.

Szlachetka DM, Kasabach-Merrit syndrome: a case review.

Neonat. Network. 1998;17:7-15.

Mitsuoka H., Unno N. Takei Y. Saito T. Ishimaru K. Miki K.

Nakamura S. Videodensitometric blood flow analysis of

abdominal aortic aneurysm and intravascular coagulation.

Journal of Vascular Surgery. 2003;38(2):340-5.

Kurukulasuriya AP. Fragmented red cells,

thrombocytopaenia and elevated D-dimers do not always

indicate the presence of disse minated intravascularr

coagulation, even in the prese nce of a bleeding tendency.

Ceylon Medical Journal. 2003;48(2):61.

Contrino J, Hair G, Kreutzer D, Rickles FR. In situ detection

of expression of tissue factor in vascular endothelial cells :

correlation with the malignant phenotype of human breast

tissue. Nature Med. 1996;209-15.

Zhang Y, Deng Y, Luther T, Muller M, Ziegler R, Waldherr

R, Stern DM, Nawroth PP. Tissue factor controls the balance

of angiogenic and antiangiogenic properties of tumor cells in

mice, J Clin Invest. 1994;94:1320-7.

Falanga A, Consonni R, Marchetti M, Locatelli G, Garattini

E, Passerini G, et al. Cancer procoagulant and tissue factor

are differently modulated by all -trans-retinoic acid in acute

promyelocytic leukemia cells Blood. 1998;92:143-51.

Ozturk M, Senqul N. Global f ibrinolytic capacity in

colorectal cancer: a new clue to occult fibrinoly sis. Clinical

& Applied Thrombosis/Haemostasis. 2003;92:151-4.

Horan JT, Francis CW. Fibrin d egradation products, fibrin

monomer and soluble fibrin in disseminated intravascular

coagulation. Seminars in Throm bosis & Haemostasis.

;27(6):657-66.

Bonnar J. Massive obstetric ha emorrhage. Baillieres Best

Pract Res Clin Obstet Gynaecol. 2000;14(1):1-18.

Trenk D, Althen H, Jähnchen E, Meinertz T, and S. Øie.

Factors responsible for interindividual differences in the dose

requirement of phenprocoumon. European Journal of Clinical

Pharmacology, 1987;33(1).

Tang B., McKenna P. and Rovit: Primary Fibrinolytic

Syndrome Associated with Subar achnoid Hemorrhage.

Angiology, 1973 Nov.;627-34.

Downloads